zepbound weight loss drug review

Zepbound is a newly approved weight-loss drug that contains the active ingredient tirzepatide, which is also found in the diabetes drug Mounjaro. It is an injectable prescription medicine that may help adults with obesity or excess weight who also have weight-related medical problems. Zepbound is the first and only approved treatment activating two incretin hormone receptors, GIP and GLP-1, to tackle an underlying cause of excess weight. In clinical trials, adults taking Zepbound lost an average of 48 pounds at the highest dose. The drug is recommended for use in people who have obesity or who are overweight with at least one weight-related condition such as high blood pressure, and it should be used along with a lower calorie diet and regular physical activity. The active ingredient tirzepatide mimics a hormone that helps reduce food cravings, and at lower doses, patients also lost weight. Zepbound is expected to be available shortly after Thanksgiving. The product is given in six injectable doses and is expected to be available at a list price of $1,059. It is important to note that physicians should closely monitor people who take the medication.